COMMUNIQUÉS West-GlobeNewswire

Pluri Partners with Miss Universe Skincare Introducing Exosome-Enhanced Regenerative Skincare
11/11/2025
Pluri launches wholly-owned health and aesthetics subsidiary Cellav- leveraging Pluri’s proprietary 3D cell expansion platform to deliver advanced exosome-based technologies for medical aesthetics The partnership with [...]
Solid Biosciences to Participate at Upcoming Investor Conferences
11/11/2025
CHARLESTOWN, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac [...]
Lexicon Pharmaceuticals to Participate at the Jefferies 2025 London Healthcare Conference
11/11/2025
THE WOODLANDS, Texas, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Jefferies 2025 London Healthcare [...]
Alpha Tau to Participate at Jefferies Global Healthcare Conference in London
11/11/2025
JERUSALEM, Nov. 11, 2025 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced [...]
rYojbaba Co., Ltd. Joins Guardian Girls International (GGI) as an Official Partner for the Guardian Girls Ju-Jitsu Project
11/11/2025
FUKUOKA, Japan, Nov. 11, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor consulting and health services company, building on its previously announced [...]
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
11/11/2025
Target Loadings of 4% and 5% Rapamycin Achieved for Topical Lotion and Dermal Patch Delivery Technologies Respectively Clinical Trial and Stability Batch Manufacture to Commence in Q4 2025 Clinical Testing in a Number [...]
Grace Therapeutics Announces Abstract Accepted for Presentation at Society of Vascular and Interventional Neurology Annual Meeting
11/11/2025
STRIVE-ON Results Accepted for Late-Breaking Presentation PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company [...]
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
11/11/2025
Bagsværd, Denmark, 11 November 2025 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons in accordance [...]
Altimmune Announces Publication of IMPACT Phase 2b Trial Data in The Lancet and Concurrent Late-Breaking Oral Presentation at AASLD The Liver Meeting® 2025
11/11/2025
24-week data demonstrated significant MASH resolution and weight loss, and strong evidence of anti-fibrotic activity with a favorable tolerability profile Significant improvements observed in secondary endpoints, [...]
Coloplast A/S - Notice of Annual General Meeting 2025
11/11/2025
Notice of Annual General Meeting 2025 The Annual General Meeting of Coloplast A/S will be held on Thursday, 4 December 2025 at 3:30 pm CET at the premises of Coloplast A/S, Holtedam 3 in Humlebæk (the Aage Louis-Hansen [...]
Applied StemCell Demonstrates Efficient Knock-In of a 50 kb DNA Construct into Human iPSCs Using TARGATT™ Technology
11/11/2025
MILPITAS, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Applied StemCell, Inc. (ASC), today announced the successful knock-in of a 50 kilobase (kb) multifunctional DNA insert into human induced pluripotent stem cells (iPSCs [...]
RadNet Acquires CIMAR UK, Empowering DeepHealth to Accelerate AI-Powered Imaging, Reporting and Image-Based Screening
11/11/2025
Acquisition supplements CIMAR’s cloud-native infrastructure with DeepHealth’s AI-powered informatics to deliver connected, efficient and accessible care LOS ANGELES and LONDON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- RadNet, [...]
Ariceum Therapeutics Doses First Patient in SANTANA-225 Phase 1/2 Clinical Trial of 225Ac-SSO110 in Patients with Extensive-Stage Small Cell Lung Cancer or Merkel Cell Carcinoma
11/11/2025
225Ac-SSO110 has received U.S. FDA Orphan Drug Designation Initial safety data from SANTANA-225 in ES-SCLC and MCC expected in 2026 Potential to address a broad range of neuroendocrine cancers BERLIN, Nov. 11, 2025 ( [...]
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
11/11/2025
BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming the treatment of autoimmune diseases, today announced the pricing of an [...]
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
11/11/2025
TORONTO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based [...]
La Croix-Rouge canadienne déploie une clinique médicale d’urgence en Jamaïque
11/11/2025
Des spécialistes humanitaires sont mobilisés pour porter secours aux personnes touchées par l’ouragan Melissa OTTAWA, Ontario, 10 nov. 2025 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne, en collaboration avec la [...]
Canadian Red Cross sending emergency medical clinic to Jamaica
11/11/2025
Humanitarian experts deploying to help people impacted by Hurricane Melissa OTTAWA, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- In response to the devastating impact of Hurricane Melissa across the Caribbean region, the [...]
Regional Health Properties, Inc. Reports Sale of Skilled Nursing Facility
10/11/2025
Atlanta, GA, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional,” the “Company,” “we,” “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced the completion [...]
Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley
10/11/2025
COPENHAGEN, Denmark, November 10, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 4,94 [...]

Pages